Coronavirus – EiriGlobal

Govt panel allows phase-3 trial of Covovax as booster dose in adults

An expert panel of India’s central drug authority has recommended permission for conducting a phase-3 clinical trial of Covid vaccine

Delhi on Thursday reported 326 fresh COVID-19 cases and three deaths, while the positivity rate stood at 0.77 percent, according to

Biological E has sought emergency use authorisation from India’s drug regulator for its COVID-19 vaccine Corbevax for the 12 to

The weekend curfew in the national capital has been lifted, along with restrictions at markets and malls. Cinema halls and restaurants

A total of 21,914 families who have lost their loved ones to COVID-19 in Delhi have received a one-time ex-gratia

A new coronavirus variant Deltacron has emerged in Cyprus which has a similar genetic background to the Delta variant, as well as

By Administrator_India Capital Sands The US economy grew solidly in the second quarter (Q2), pulling the level of gross domestic product (GDP) above

By Administrator_ India Capital Sands Ahmedabad-based pharma major Cadila Healthcare (Zydus Cadila) is planning to start clinical trials on children

By Administrator_India Capital Sands As many as 42,640 fresh COVID-19 infections were reported in the last 24 hours, the lowest

By Administrator_ India Capital Sands India’s Covid chart continued to improve today with the country recording 1.06 lakh cases, a